Yasmin SRITAPAN, Sean CLIFFORD, Alexander BAUTISTA

Perioperative Management of Patients on Buprenorphine and Methadone: A Narrative Review

The opioid epidemic has emerged as a major health and socialproblem over the last few decades. An increasing number of patientswith opioid use disorder are presenting for perioperative management.These patients are either on buprenorphine or methadone for themaintenance and treatment of opioid addiction or chronic pain. Inthe settings of acute pain, the optimal management of patients withopioid use disorder is challenging, and recovery can be jeopardizedsecondary to the unique pharmacology of these agents. The purposeof this narrative review is to summarize the existing studies on theperioperative management of patients who are using buprenorphineand methadone and provide guidance for the management of patientswith opioid use disorder during the perioperative period

PDF

___

1. Dahlhamer J, Lucas J, Zelaya C, Nahin R, Mackey S, DeBar L, et al. Prevalence of Chronic Pain and High Impact Chronic Pain Among Adults - United States 2016. MMWR Morb Mortal Wkly Rep. 2018;67:1001-6
2. US Department of Health and Human Services, accessed 22 January 2020, https:// www.hhs.gov/opioids
3. National Governors Association. A Compact to Fight Opioid Addiction. 2016, accessed 30 March 2020, https://www.nga.org/wp-content/uploads/2019/01/NGAOpioid-Compact-State-Reporting-Chart-003.pdf
4. Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and metaanalysis of cohort studies. BMJ 2017;357:j1550.
5. Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev 2016:CD011117.
6. Jonan AB, Kaye AD, Urman RD. Buprenorphine Formulations: Clinical Best Practice Strategies Recommendations for Perioperative Management of Patients Undergoing Surgical or Interventional Pain Procedures. Pain Physician 2018;21:1-12.
7. Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 1994;55:569- 80.
8. Martin YN, Pearson ACS, Tranchida JR, Weingarten TN, Schulte PJ, Sprung J. Implications of uninterrupted preoperative transdermal buprenorphine use on postoperative pain management. Reg Anesth Pain Med 2019 Jan 11;rapm-2018- 100018. doi: 10.1136/rapm-2018-100018. Online ahead of print.
9. Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend 2003;70(2 Suppl):13-27.
10. Greenwald M, Johanson CE, Bueller J, Chang Y, Moody DE, Kilbourn M, et al. Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. Biol Psychiatry 2007;61:101-10.
11. Elkader A, Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet 2005;44:661-80.
12. Johnson RE, Strain EC, Amass L. Buprenorphine: how to use it right. Drug Alcohol Depend 2003;70(2 Suppl):59-77.
13. Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage 2005;29:297-326.
14. Corkery JM, Schifano F, Ghodse AH, Oyefeso A. The effects of methadone and its role in fatalities. Hum Psychopharmacol 2004;19:565-76.
15. Wolff K. Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther Drug Monit 2002;24:457-70.
16. Peng PWH, Tumber PS, Gourlay D. Review article: perioperative pain management of patients on methadone therapy. Can J Anaesth 2005;52:513-23.
17. Dematteis M, Auriacombe M, D’Agnone O, Somaini L, Szerman N, Littlewood R, et al. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opin Pharmacother 2017;18:1987- 99.
18. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 2002;137:501-4.
19. Ward EN, Quaye AN, Wilens TE. Opioid Use Disorders: Perioperative Management of a Special Population. Anesth Analg 2018;127:539-47.
20. Anderson TA, Quaye ANA, Ward EN, Wilens TE, Hilliard PE, Brummett CM. To Stop or Not, That Is the Question: Acute Pain Management for the Patient on Chronic Buprenorphine. Anesthesiology 2017;126:1180-6.
21. Coluzzi F, Bifulco F, Cuomo A, Dauri M, Leonardi C, Melotti RM, et al. The challenge of perioperative pain management in opioid-tolerant patients. Ther Clin Risk Manag 2017;13:1163-73.
22. McCormick Z, Chu SK, Chang-Chien GC, Joseph P. Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle’s disease: a case report and review. Pain Med 2013;14:1187- 91.
23. Hansen LE, Stone GL, Matson CA, Tybor DJ, Pevear ME, Smith EL. Total Joint Arthroplasty in Patients Taking Methadone or Buprenorphine/Naloxone Preoperatively for Prior Heroin Addiction: A Prospective Matched Cohort Study. J Arthroplasty 2016;31:1698-701.
24. Brummett CM, Trivedi KA, Dubovoy AV, Berland DW. Dexmedetomidine as a novel therapeutic for postoperative pain in a patient treated with buprenorphine. J Opioid Manag 2009;5:175-9.
25. Martin YN, Deljou A, Weingarten TN, Schroeder DR, Sprung J. Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series. BMC Anesthesiol 2019;19:68.
26. Macintyre PE, Russell RA, Usher KAN, Gaughwin M, Huxtable CA. Pain relief and opioid requirements in the first 24 hours after surgery in patients taking buprenorphine and methadone opioid substitution therapy. Anaesth Intensive Care 2013;41:222-30.
27. Cornett EM, Kline RJ, Robichaux SL, Green JB, Anyama BC, Gennuso SA, et al. Comprehensive Perioperative Management Considerations in Patients Taking Methadone. Curr Pain Headache Rep 2019;23:49.
28. Barelli R, Morelli Sbarra G, Sbaraglia F, Zappia L, Rossi M. Prevention of postoperative hyperalgesia in a heroin-addicted patient on methadone maintenance. J Clin Pharm Ther 2019;44:397-9.
29. Haller G, Waeber JL, Infante NK, Clergue F. Ketamine combined with morphine for the management of pain in an opioid addict. Anesthesiology 2002;96:1265-6.
30. Kaye AD, Alian AA, Vadivelu N, Chung KS. Perioperative dilemma: challenges of the management of a patient on mega doses of morphine and methadone. J Opioid Manag 2014;10:69-72.
31. Gowing L, Ali R, White JM. Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database Syst Rev 2017;5:CD002021.
32. May JA, White HC, Leonard-White A, Warltier DC, Pagel PS. The patient recovering from alcohol or drug addiction: special issues for the anesthesiologist. Anesth Analg 2001;92:1601-8.
33. Strommen M, Helland A, Kulseng B, Spigset O. Bioavailability of Methadone After Sleeve Gastrectomy: A Planned Case Observation. Clin Ther 2016;38:1532-6.
34. Committee on Standards and Practice Parameters, Apfelbaum JL, Connis RT, Nickinovich DG; American Society of Anesthesiologists Task Force on Preanesthesia Evaluation, Pasternak LR, Arens JF, Caplan RA, Connis RT, et al. Practice advisory for preanesthesia evaluation: an updated report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology 2012;116:522-38.
35. White JM. Pleasure into pain: the consequences of long-term opioid use. Addict Behav 2004;29:1311-24.
36. Doverty M, Somogyi AA, White JM, Bochner F, Beare CH, Menelaou A, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 2001;93:155-63.
37. Chan FJ, Schwartz AM, Wong J, Chen C, Tiwari B, Kim SJ. Use of Chronic Methadone Before Total Knee Arthroplasty. J Arthroplasty 2017;32:2105-7.
38. Chern SYS, Isserman R, Chen L, Ashburn M, Liu R. Perioperative Pain Management for Patients on Chronic Buprenorphine: A Case Report. J Anesth Clin Res 2013;3:1000250.
39. Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med 2006;144:127-34.
40. Mao J, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995;61:353-64.
41. Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg 1993;77:1048-56.
42. Weinbroum AA. Non-opioid IV adjuvants in the perioperative period: pharmacological and clinical aspects of ketamine and gabapentinoids. Pharmacol Res 2012;65:411-29.
43. Harrison TK, Kornfeld H, Aggarwal AK, Lembke A. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy. Anesthesiol Clin 2018;36:345-59.
44. Jasinski DR. Tolerance and dependence to opiates. Acta Anaesthesiol Scand 1997;41:184-6.
45. Boyle RK. Intra- and postoperative anaesthetic management of an opioid addict undergoing caesarean section. Anaesth Intensive Care 1991;19:276-9.
46. Sevarino FB, Sinatra RS, Paige D, Silverman DG. Intravenous ketorolac as an adjunct to patient-controlled analgesia (PCA) for management of postgynecologic surgical pain. J Clin Anesth 1994;6:23-7.
47. Fishman SM, Wilsey B, Mahajan G, Molina P. Methadone reincarnated: novel clinical applications with related concerns. Pain Med 2002;3:339-48.
48. Silva MJ, Rubinstein A. Continuous Perioperative Sublingual Buprenorphine. J Pain Palliat Care Pharmacother 2016;30:289-93.
49. Huang A, Katznelson R, de Perrot M, Clarke H. Perioperative management of a patient undergoing Clagett window closure stabilized on Suboxone® for chronic pain: a case report. Can J Anaesth 2014;61:826-31.
50. Khelemsky Y, Schauer J, Loo N. Effect of buprenorphine on total intravenous anesthetic requirements during spine surgery. Pain Physician 2015;18:E261-E4. 51. Kornfeld H, Manfredi L. Effectiveness of full agonist opioids in patients stabilized on buprenorphine undergoing major surgery: a case series. Am J Ther 2010;17:523-8.